BioWorld Asia

Sep. 27, 2006

View Archived Issues

Merck KGaA Buying Serono, Giving CHF16.6B Valuation

Merck KGaA agreed to acquire a controlling stake in Serono SA by purchasing the Bertarelli family's shares in the company, which represent 64.5 percent of its equity and 75.5 percent of its voting rights. (BioWorld International) Read More

GPC Biotech Shares Jump On Prostate Cancer Study Results

Read More

Proteomics Approach Could Bring Rapid Dipstick For TB

Read More

Another European Agenda For Innovative Medicines

Read More

Jerini Shares Plummet On Mixed Phase III Trial News

Read More

India's Avesthagen Seeking VC Money, Eyeing 2008 IPO

Read More

BioAlliance Pharma Reports Phase I/II Doxorubicin Data

Read More

Europe Trails U.S. In Tech Transfer; Patents Lag, Too

Read More

Other News To Note

Read More